The Value of Mandatory Second Opinion Pathology Review of Prostate Needle Biopsy Interpretation Before Radical Prostatectomy

Journal of Urology

Volumn 184, Issue 1, 2010, Pages 126-130

  Brimo, Fadi ^a   Schultz, Luciana ^a   Epstein, Jonathan I ^a  

^a JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

adenocarcinoma; biopsy; diagnosis; pathology; prostate

Indexed keywords

ARTICLE; BENIGN TUMOR; CANCER INVASION; CANCER RISK; GLEASON SCORE; HUMAN; MAJOR CLINICAL STUDY; MALE; MANDATORY REPORTING; NEEDLE BIOPSY; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATECTOMY;

ADENOCARCINOMA; BIOPSY, NEEDLE; HUMANS; MALE; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PROSTATECTOMY; PROSTATIC NEOPLASMS; REFERRAL AND CONSULTATION;

EID: 77953123852     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2010.03.021     Document Type: Article

References (29)

1. Epstein J.I., Walsh P.C., and Sanfilippo F. Clinical and cost impact of second-opinion pathology. Review of prostate biopsies prior to radical prostatectomy. Am J Surg Pathol 20 (1996) 851
2. Gupta D., and Layfield L.J. Prevalence of inter-institutional anatomic pathology slide review: a survey of current practice. Am J Surg Pathol 24 (2000) 280
3. Kronz J.D., Westra W.H., and Epstein J.I. Mandatory second opinion surgical pathology at a large referral hospital. Cancer 86 (1999) 2426
4. Rosen P.P. Review of 'outside' pathology before treatment should be mandatory. Am J Surg Pathol 26 (2002) 1235
5. Weir M.M., Jan E., and Colgan T.J. Interinstitutional pathology consultations. A reassessment. Am J Clin Pathol 120 (2003) 405
6. Silverberg S.G. The institutional pathology consultation. Documentation of its importance in patient management. Arch Pathol Lab Med 119 (1995) 493
7. Magi-Galluzzi C., and Epstein J.I. Threshold for diagnosing prostate cancer over time. Hum Pathol 34 (2003) 1116
8. Epstein J.I., Chan D.W., Sokoll L.J., et al. Nonpalpable stage T1c prostate cancer: prediction of insignificant disease using free/total prostate specific antigen levels and needle biopsy findings. J Urol 160 (1998) 2407
9. Eisenberg J.M. Economics. JAMA 273 (1995) 1670
10. Monaco G.P., and Goldschmidt P. What is proper cancer care in the era of managed care?. Oncology (Williston Park) 11 (1997) 65
11. Abt A.B., Abt L.G., and Olt G.J. The effect of interinstitution anatomic pathology consultation on patient care. Arch Pathol Lab Med 119 (1995) 514
12. Wetherington R.W., Cooper H.S., Al-Saleem T., et al. Clinical significance of performing immunohistochemistry on cases with a previous diagnosis of cancer coming to a national comprehensive cancer center for treatment or second opinion. Am J Surg Pathol 26 (2002) 1222
13. Chafe S., Honore L., Pearcey R., et al. An analysis of the impact of pathology review in gynecologic cancer. Int J Radiat Oncol Biol Phys 48 (2000) 1433
14. Jacques S.M., Qureshi F., Munkarah A., et al. Interinstitutional surgical pathology review in gynecologic oncology: II. Endometrial cancer in hysterectomy specimens. Int J Gynecol Pathol 17 (1998) 42
15. Harris M., Hartley A.L., Blair V., et al. Sarcomas in north west England: I. Histopathological peer review. Br J Cancer 64 (1991) 315
16. Prescott R.J., Wells S., Bisset D.L., et al. Audit of tumour histopathology reviewed by a regional oncology centre. J Clin Pathol 48 (1995) 245
17. Kim H., Zelman R.J., Fox M.A., et al. Pathology Panel for Lymphoma Clinical Studies: a comprehensive analysis of cases accumulated since its inception. J Natl Cancer Inst 68 (1982) 43
18. Segelov E., Cox K.M., Raghavan D., et al. The impact of histological review on clinical management of testicular cancer. Br J Urol 71 (1993) 736
19. Selman A.E., Niemann T.H., Fowler J.M., et al. Quality assurance of second opinion pathology in gynecologic oncology. Obstet Gynecol 94 (1999) 302
20. Wurzer J.C., Al-Saleem T.I., Hanlon A.L., et al. Histopathologic review of prostate biopsies from patients referred to a comprehensive cancer center: correlation of pathologic findings, analysis of cost, and impact on treatment. Cancer 83 (1998) 753
21. Wayment R.O., Bourne A., Kay P., et al. Second opinion pathology in tertiary care of patients with urologic malignancies. Urol Oncol (2009) Epub ahead of print
22. Thomas C.W., Bainbridge T.C., Thomson T.A., et al. Clinical impact of second pathology opinion: a longitudinal study of central genitourinary pathology review before prostate brachytherapy. Brachytherapy 6 (2007) 135
23. Epstein J.I., Allsbrook Jr. W.C., Amin M.B., et al. The 2005 International Society of Urological Pathology (ISUP) consensus conference on Gleason grading of prostatic carcinoma. Am J Surg Pathol 29 (2005) 1228
24. Latour M., Amin M.B., Billis A., et al. Grading of invasive cribriform carcinoma on prostate needle biopsy: an interobserver study among experts in genitourinary pathology. Am J Surg Pathol 32 (2008) 1532
25. Qian J., Jenkins R.B., and Bostwick D.G. Detection of chromosomal anomalies and c-myc gene amplification in the cribriform pattern of prostatic intraepithelial neoplasia and carcinoma by fluorescence in situ hybridization. Mod Pathol 10 (1997) 1113
26. Fajardo D.A., and Epstein J.I. Fragmentation of prostatic needle biopsy cores containing adenocarcinoma: the role of specimen submission. BJU Int 105 (2009) 172
27. Brimo F., Vollmer R.T., Corcos J., et al. Prognostic value of various morphometric measurements of tumour extent in prostate needle core tissue. Histopathology 53 (2008) 177
28. Bismar T.A., Lewis Jr. J.S., Vollmer R.T., et al. Multiple measures of carcinoma extent versus perineural invasion in prostate needle biopsy tissue in prediction of pathologic stage in a screening population. Am J Surg Pathol 27 (2003) 432
29. Bastacky S.I., Walsh P.C., and Epstein J.I. Relationship between perineural tumor invasion on needle biopsy and radical prostatectomy capsular penetration in clinical stage B adenocarcinoma of the prostate. Am J Surg Pathol 17 (1993) 336